What the FDA labels say about taking them together
Blinatumomab and dexamethasone
Blinatumomab's FDA label of April 14, 2026 names dexamethasone in its warnings and precautions section; the dexamethasone labels PlainMeds reads (4) do not name blinatumomab. The blinatumomab label: “Management of pancreatitis may require either temporary interruption or discontinuation of BLINCYTO and dexamethasone.”
Check it at the source: the blinatumomab FDA label on DailyMed (effective April 14, 2026, Amgen, Inc); the dexamethasone FDA label on DailyMed (effective June 6, 2025, Hikma Pharmaceuticals USA, Inc.).
What does the blinatumomab label say about dexamethasone?
Blinatumomab label, warnings and precautionsManagement of pancreatitis may require either temporary interruption or discontinuation of BLINCYTO and dexamethasone [see Dosage and Administration (2.4) ].
Source: FDA drug label (BLINCYTO), Amgen, Inc, effective April 14, 2026 (SPL set 38b482a8-960b-4591-9857-5031ecb830aa), via openFDA; the full label on DailyMed
What does the dexamethasone label say about blinatumomab?
Dexamethasone's label (effective June 6, 2025) and its 3 other brand-application labels do not name blinatumomab in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Dexamethasone Intensol), Hikma Pharmaceuticals USA, Inc., effective June 6, 2025 (SPL set b15200fb-1826-472b-a907-e677a272513b), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Blinatumomab | Dexamethasone | |
|---|---|---|
| Labeled for | Leukemia, lymphoma and myeloma | Asthma, Eczema (atopic dermatitis), Leukemia, lymphoma and myeloma, Herpes and shingles, Crohn's disease and ulcerative colitis, Multiple sclerosis, Osteoarthritis, Rheumatoid arthritis, Psoriasis, Allergies, Anemia, Pain |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | n/a | $0.193 per tablet 4 mg tablet |
| Shortage now | No current entry | In shortage |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once